Clinical study on treatment of children attention deficit hyperactivity disorder by jiangqian granule.
- Author:
Jian CHEN
1
;
Yu-yan CHEN
;
Xiao-ming WANG
Author Information
- Publication Type:Clinical Trial
- MeSH: Attention Deficit Disorder with Hyperactivity; blood; drug therapy; Central Nervous System Stimulants; therapeutic use; Child; Drug Therapy, Combination; Drugs, Chinese Herbal; therapeutic use; Female; Humans; Lead; blood; Male; Methylphenidate; therapeutic use; Phytotherapy
- From: Chinese Journal of Integrated Traditional and Western Medicine 2002;22(4):258-260
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the effect of Jiangqian granule (JQG) in treating children attention deficit hyperactivity disorder (ADHD) and its mechanism.
METHODSEighty children with ADHD were randomly divided into two groups, the treated group treated with JQG and the control group treated with Ritalin. Blood lead concentration and Conners' scoring were measured before and after 3 months treatment and the therapeutic effects were assessed. Besides, blood lead concentration and Conners' scoring in 60 healthy children were also determined for control.
RESULTSThe total effective rate in the treated group and the control group was 92.5% and 72.5% respectively, significant difference existed between the two groups. Blood lead level and Conners' scores in ADHD patients were significantly higher than those in the healthy control (P < 0.01). The two parameters decreased after treatment in both groups, but the lowering was more significant in the treated group (P < 0.05, P < 0.01).
CONCLUSIONBlood lead concentration raised in ADHD patients, JQG could enhance the clinical therapeutic effect by means of reducing the blood lead.
